Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Gannett Q1 Profit Down - Quick Facts

RELATED NEWS
Trade GCI now with 

Gannett Co., Inc. (GCI: Quote) reported that its first-quarter net income attributable to the company declined to $68.22 million, from $90.49 million in the same quarter last year. Earnings per share, on a GAAP basis were $0.28 for the first quarter of 2012 compared to $0.37 for the first quarter last year.

Excluding special items in 2012 and 2011, first quarter earnings per share were $0.34 compared to $0.41 for the same quarter in 2011. Analysts polled by Thomson Reuters expected the company to report earnings of $0.31 per share for the quarter. Analysts' estimates typically exclude special items.

Total operating Revenues for the quarter declined to $1.22 billion from $1.25 billion in the prior year quarter. Seven analysts had consensus revenue estimate of $1.24 billion for the quarter.

Click here to receive FREE breaking news email alerts for Gannett Co. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving modestly higher in morning trading, stocks showed a substantial move to the downside over the course of the trading day on Wednesday. The major averages pulled back well off their highs for the session, sliding firmly into negative territory. Ebola "czar" Ron Kain is scheduled to meet with President Barack Obama on Wednesday as he begins his efforts to coordinate the government's response to the deadly disease. Klain, who previously served as chief of staff to Vice President Joe Biden and then-Vice President Al Gore, was named as Ebola Response Coordinator last Friday. Potentially complicating the outlook for control of the Senate, the results of a SurveyUSA poll conducted for WXIA-TV in Atlanta suggest that the Georgia Senate race between Republican David Perdue and Democrat Michelle Nunn could be headed for a runoff.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.